Katie Mazuk is the Vice-President of Clinical Insights and Experience within the Global Clinical Development Operations (GCDO) organization at Janssen Pharmaceuticals Companies of Johnson & Johnson. In this role, Katie has responsibility for curating clinical trial insights to support operational strategy, delivering data-driven clinical trial feasibility and data science capability, in addition to oversight of the clinical trial portfolio. Katie also leads strategy and deployment for Janssen’s investigator and patient clinical trial experience, inclusive of patient engagement activities for recruitment and retention, serving as an integral player in embedding Janssen’s approach to patient and investigator engagement across the entire organization.
Katie previously served as Senior Director, Head Investigator and Patient Engagement, within Global Clinical Operations, leading the division responsible for planning and development of strategies to increase customer engagement, investigator relations and patient centricity in clinical trials. Leading up to that role, she was Director, Patient Solutions & Systems, within the Neuroscience Systems of Care Team, part of Janssen North America Sales & Marketing. In this role, Katie drove the development, alignment, and implementation of operational strategies, marketing resources, and infrastructure associated with delivery of the Janssen Connect®, a patient and healthcare provider support program. Katie also served as the Neuroscience Therapeutic Area Lead for Janssen CarePath as well as the lead for the Neuroscience long term strategy, Schizophrenia 2020.
In her previous role as Director, Global Head of Trial Supply Management, she led the Trial Supply Managers, Logistics Managers and Temperature Management & Control teams for Janssen Research & Development. She was responsible for customer relationship management, demand management, inventory management and medication delivery services for the Pharmaceutical R&D Portfolio. In this capacity, Katie was a member of the Janssen Pharma R&D Clinical Supply Chain Leadership Team.
Katie also served as the Associate Director, Program Management where she led the strategy development and project governance for the Supply Management organization. Concurrently with this role, she completed a two-year International Development Program assignment in Belgium.
Katie started her career at Johnson & Johnson Pharmaceutical Research & Development as a Manager of Global Clinical Supplies responsible for the XARELTO®, VELCADE®, TOPAMAX® and NATRECOR® clinical programs. Before joining Johnson & Johnson, she worked in a variety of operational, project management and business development positions at Xerimis, Inc., a contract manufacturing organization.
Katie holds a Bachelor of Science degree from Clemson University and her Masters of Business Administration from The Wharton School of the University of Pennsylvania.